Paladin Labs Inc.

Paladin Labs Inc.

November 28, 2007 16:00 ET

Paladin to be Inducted Into the Canadian Healthcare Marketing Hall of Fame

MONTREAL, CANADA--(Marketwire - Nov. 28, 2007) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, proudly announces that they have been selected for induction in the 2007 Canadian Healthcare Marketing Hall of Fame. This award is presented with particular regard to Paladin's efforts in marketing Plan B.

"The IMS Health Team Awards were devised to honor significant accomplishments by pharmaceutical marketing groups in Canada. They are handed out rarely, and up until this year have only gone to the largest multinationals: Merck Frosst, Eli Lilly, Pfizer and Allergan. That Paladin Labs, a Canadian company, is being recognized in 2007 is evidence that their efforts have attracted the notice and admiration of the pharma industry. It is a major achievement," said Mitchell Shannon, publisher of the Chronicle of Healthcare Marketing.

"We are proud of all of the hard work and effort that has gone into creating the marketing for Plan B. Our success could not have been achieved without the dedication of the entire Paladin team, and we look forward to continued success in the years ahead", said Jonathan Ross Goodman, President and CEO.

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at

This news release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2006. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether a result of new information, future events, or except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at

Contact Information